Normal bone health in young adults with 21-hydroxylase enzyme deficiency undergoing glucocorticoid replacement therapy
Sign Up to like & getrecommendations! Published in 2021 at "Osteoporosis International"
DOI: 10.1007/s00198-021-06097-w
Abstract: It is of great importance to investigate any potential detrimental effect on bone health in young adults with 21-hydroxylase enzyme deficiency undergoing glucocorticoid replacement therapy. This study demonstrated normal bone health in well-controlled patients. Additionally,… read more here.
Keywords: femoral neck; hydroxylase enzyme; bone health; bone ... See more keywords